Indivior (LON:INDV) Shares Down 17% – Should You Sell?

Indivior PLC (LON:INDV) was down 17% on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 720.60 ($9.07). Approximately 2,904,792 shares changed hands during mid-day trading, an increase of 294% from the average daily volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.65) price target on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 13.2 %

The business has a 50 day simple moving average of GBX 928.06 and a 200-day simple moving average of GBX 853.71. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The stock has a market capitalization of £1.18 billion, a price-to-earnings ratio of -624.35, a PEG ratio of -5.57 and a beta of 0.19.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.